Total Payments
$45,477
2024 Payments
$2,542
Companies
17
Transactions
163
Medicare Patients
1,020
Medicare Billing
$222,183
Payment Breakdown by Category
Other$35,810 (78.7%)
Food & Beverage$5,793 (12.7%)
Travel$2,824 (6.2%)
Consulting$1,050 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $30,000 | 2 | 66.0% |
| Food and Beverage | $5,793 | 145 | 12.7% |
| Honoraria | $5,790 | 1 | 12.7% |
| Travel and Lodging | $2,824 | 13 | 6.2% |
| Consulting Fee | $1,050 | 1 | 2.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19.84 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $15,191 | 2 | $0 (2021) |
| Medtronic, Inc. | $15,000 | 1 | $0 (2021) |
| Amneal Pharmaceuticals LLC | $7,440 | 22 | $0 (2024) |
| Sage Therapeutics, Inc. | $2,387 | 16 | $0 (2023) |
| Biogen, Inc. | $1,823 | 16 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $775.54 | 9 | $0 (2024) |
| ABBVIE INC. | $599.43 | 18 | $0 (2024) |
| Kyowa Kirin, Inc. | $532.94 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $423.39 | 15 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $418.15 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,542 | 49 | Amneal Pharmaceuticals LLC ($1,239) |
| 2023 | $8,963 | 63 | Amneal Pharmaceuticals LLC ($6,155) |
| 2022 | $3,781 | 48 | Biogen, Inc. ($1,783) |
| 2021 | $30,191 | 3 | BOSTON SCIENTIFIC CORPORATION ($15,191) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Neuropsychiatry | ||||||
| 11/18/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ACADIA Pharmaceuticals Inc | — | Food and Beverage | In-kind items and services | $14.77 | General |
| 11/11/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/05/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/23/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Neurology | ||||||
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $125.83 | General |
| Category: Neuropsychiatry | ||||||
| 08/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Central Nervous System | ||||||
| 08/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Neuropsychiatry | ||||||
| 08/14/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: NEUROLOGY | ||||||
| 07/15/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Adenosine A2A Receptors | ||||||
| 07/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Central Nervous System | ||||||
| 06/19/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $111.33 | General |
| 06/13/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: NEUROLOGY | ||||||
| 06/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Central Nervous System | ||||||
| 06/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $116.12 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 722 | 6,748 | $228,413 | $174,137 |
| 2022 | 6 | 196 | 327 | $51,600 | $34,979 |
| 2021 | 4 | 102 | 106 | $46,136 | $13,068 |
Total Patients
1,020
Total Services
7,181
Medicare Billing
$222,183
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 260 | 766 | $101,296 | $77,937 | 76.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 120 | 196 | $36,336 | $27,028 | 74.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 18 | 5,301 | $35,043 | $26,032 | 74.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 166 | $15,528 | $11,925 | 76.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 62 | 97 | $12,708 | $9,963 | 78.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $8,947 | $6,834 | 76.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 42 | 51 | $4,771 | $3,667 | 76.9% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 11 | 23 | $3,755 | $2,944 | 78.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 22 | 22 | $2,877 | $2,255 | 78.4% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 22 | 42 | $2,601 | $2,039 | 78.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 29 | $2,276 | $1,784 | 78.4% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 11 | 16 | $2,276 | $1,728 | 75.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 158 | $22,970 | $16,413 | 71.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $9,630 | $5,792 | 60.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 32 | $7,983 | $4,590 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 56 | $5,872 | $4,171 | 71.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 36 | $3,422 | $2,662 | 77.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 13 | $1,723 | $1,351 | 78.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 30 | 30 | $19,920 | $5,330 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 27 | $12,528 | $3,977 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 27 | $9,288 | $2,853 | 30.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2021 | 20 | 22 | $4,400 | $907.72 | 20.6% |
About Dr. Richard Dewey, MD
Dr. Richard Dewey, MD is a Neurology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1104358878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Dewey, MD has received a total of $45,477 in payments from pharmaceutical and medical device companies, with $2,542 received in 2024. These payments were reported across 163 transactions from 17 companies. The most common payment nature is "Grant" ($30,000).
As a Medicare-enrolled provider, Dewey has provided services to 1,020 Medicare beneficiaries, totaling 7,181 services with total Medicare billing of $222,183. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Boca Raton, FL
- Active Since 03/31/2017
- Last Updated 01/28/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1104358878
Products in Payments
- ACTIVA (Device) $15,000
- VERCISE (Device) $15,000
- RYTARY (Drug) $1,195
- NUPLAZID (Drug) $760.77
- DUOPA (Drug) $512.55
- Austedo XR (Drug) $401.78
- INBRIJA (Drug) $361.11
- INGREZZA (Drug) $357.74
- Nourianz (Drug) $316.58
- NOURIANZ (Drug) $216.36
- APOKYN (Drug) $216.13
- GENERAL DBS (Device) $190.70
- Ongentys (Drug) $65.65
- AMYVID (Drug) $59.61
- BOTOX (Biological) $51.62
- HORIZANT (Drug) $48.95
- SKYCLARYS (Drug) $39.76
- GRALISE (Drug) $38.60
- VYALEV (Drug) $35.26
- Leqembi (Drug) $23.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boca Raton
Dr. Stuart Isaacson, Md, MD
Neurology — Payments: $4.9M
Neurology $4.9M
Brian Steingo, Md, MD
Neurology — Payments: $1.4M
Neurology $1.4M
Dr. Brian Costell, M.d, M.D
Neurology — Payments: $638,608
Neurology $638,608
Dr. Patricio Espinosa, Md,Mph, MD,MPH
Neurology — Payments: $215,050
Neurology $215,050
Dr. Richard Isaacson, M.d, M.D
Neurology — Payments: $140,056
Neurology $140,056
Gediminas Gliebus, M.d, M.D
Neurology — Payments: $120,507
Neurology $120,507